MedPath

A Preliminary Study on the Effect of Transcranial Direct Current Stimulation in Subjective Cognitive Degradation with Depression after COVID-19 Infectio

Not Applicable
Recruiting
Conditions
Mental and behavioural disorders
Registration Number
KCT0008056
Lead Sponsor
ational Health Insurance Service Ilsan Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

1) Adults over 19 years of age and under 65 years of age with a history of confirmed coronavirus
2) A person who subjectively complains of cognitive decline, such as memory impairment and decreased concentration, after being confirmed with COVID-19
3) A person who is diagnosed as appropriate for a depressive disorder through an evaluation according to a clinical interview with a psychiatrist (PHQ-9 scale of 5 or more)
4) A person who can read and understand the research subject's explanation and consent form, and speaks Korean
5) A person who voluntarily decides to participate in this clinical study and who agrees in writing to the automatic medical certificate subject to the study and can participate in the entire clinical study period

Exclusion Criteria

1) A person whose medical examination has found other neurological abnormalities that may cause memory impairment
2) A person with a history of uniaxial psychiatric disorders, including intellectual disabilities, schizophrenia, alcoholism, and bipolar disorder
3) A person who has been evaluated as two or more points in question 3 of HAM-D, or who has attempted suicide within the last six months
4) When it is deemed that there is a problem with attaching electrodes to the brain waves and direct current stimulation due to abnormalities in the scalp, inflammatory reactions, or other dermatological problems
5) Those who are treated with medical diagnosis that may interfere with participation in this experiment, including stroke, spasmodic disease, multiple sclerosis, cerebral palsy, huntington disease, encephalitis, meningitis, liver disease, kidney disease, etc
6) A person who has undergone surgery on cerebral blood vessels, such as brain surgery or carotid artery surgery
7) A person who is hard to understand a conversation because of hearing impairment even with hearing aids
8) A person who can't read normal letters even with glasses on because of poor eyesight
9) In addition to the above, a person who has clinically significant findings that are medically deemed inappropriate for this study by the research director or person in charge
10) A person who has experienced a decrease in cognitive ability before being confirmed to have a coronavirus infection
11) A person who experiences depression illustrations or has a history of taking antidepressants during the period from 2 months before the confirmation of the coronavirus infection to the time of the confirmation of the coronavirus infection
12) A person who has a history of taking antidepressants within the last one month

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) 1) Interference selection in the comprehensive attention test before and after tDCS application, the change in the results of the suppression continuity test / 2) The change in the Hamilton Depression scale (HAM-D) results before and after tDCS application
Secondary Outcome Measures
NameTimeMethod
1) Changes in DOT probe task results before and after tDCS application, 2) Average change in Multifactional Memory Questionnair (MMQ) results before and after tDCS application, 3) Electroencephalography (EEG) changes in activity by part of the brain
© Copyright 2025. All Rights Reserved by MedPath